Quality Management

Quality assurance protocols for the optimisation of established treatment options only use drugs which are approved for the respective disease entity. They differ from drug approval trials with regard to their legal and financial conditions. A working group within the competence network develops quality standards which are based on the Declaration of Helsinki and the "Good Clinical Practice"-Guidelines and which take the particular demands of quality assurance protocols into account. In order to ensure high quality standards, IT-based tools are developed to facilitate the design, performance and evaluation of clinical trials.

» WG Quality Managment

Due to recent progress in medicine, lymphoma patients are more frequently treated on an outpatient base. Therefore, private practices have an increasing responsibility to contribute to the further development of therapies. Within the competence network more than 80 private practices for hematology and oncology collaborate in order to establish a quality management programme for outpatients with malignant lymphomas, and to increase the number of private practices which take part in clinical trials.

» SP5: Network of Private Practices